Innovent Biologics, Inc. (HKG:1801)
Hong Kong
· Delayed Price · Currency is HKD 82.35
-0.20 (-0.24%)
Jul 8, 2025, 4:08 PM HKT
Innovent Biologics Market Cap
Innovent Biologics has a market cap or net worth of 140.77 billion as of July 8, 2025. Its market cap has increased by 138.53% in one year.
Market Cap
140.77B
Enterprise Value
135.39B
Revenue
10.03B
Ranking
n/a
PE Ratio
n/a
Stock Price
82.35
Market Cap Chart
Since October 31, 2018, Innovent Biologics's market cap has increased from 18.54B to 140.77B, an increase of 659.33%. That is a compound annual growth rate of 35.39%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 228.27B |
| Hansoh Pharmaceutical Group Company | 185.21B |
| JD Health International | 132.80B |
| WuXi Biologics | 106.60B |
| Akeso | 104.21B |
| Sino Biopharmaceutical | 100.15B |
| CSPC Pharmaceutical Group | 93.15B |
| Sichuan Kelun-Biotech Biopharmaceutical | 82.73B |